JP2024547022A5 - - Google Patents
Info
- Publication number
- JP2024547022A5 JP2024547022A5 JP2024536373A JP2024536373A JP2024547022A5 JP 2024547022 A5 JP2024547022 A5 JP 2024547022A5 JP 2024536373 A JP2024536373 A JP 2024536373A JP 2024536373 A JP2024536373 A JP 2024536373A JP 2024547022 A5 JP2024547022 A5 JP 2024547022A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nitric oxide
- kit
- citric acid
- active pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290928P | 2021-12-17 | 2021-12-17 | |
| US63/290,928 | 2021-12-17 | ||
| PCT/US2022/081754 WO2023114971A1 (en) | 2021-12-17 | 2022-12-16 | Nitric oxide-releasing nasal compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024547022A JP2024547022A (ja) | 2024-12-26 |
| JP2024547022A5 true JP2024547022A5 (enExample) | 2025-12-09 |
Family
ID=86773604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536373A Pending JP2024547022A (ja) | 2021-12-17 | 2022-12-16 | 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049841A1 (enExample) |
| EP (1) | EP4447946A4 (enExample) |
| JP (1) | JP2024547022A (enExample) |
| KR (1) | KR20240125633A (enExample) |
| CN (1) | CN118742298A (enExample) |
| AU (1) | AU2022409833A1 (enExample) |
| CA (1) | CA3240044A1 (enExample) |
| IL (1) | IL313526A (enExample) |
| WO (1) | WO2023114971A1 (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1871433B1 (en) * | 2005-03-24 | 2009-04-22 | NOLabs AB | Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor |
| EP1888510A4 (en) * | 2005-05-27 | 2013-01-16 | Univ North Carolina | NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS |
| WO2010044875A2 (en) * | 2008-10-16 | 2010-04-22 | Novan, Inc. | Nitric oxide releasing particles for oral care applications |
| AU2015229626B2 (en) * | 2014-03-14 | 2021-05-20 | Sanotize Research And Development Corp. | Treating diseases using nitric oxide releasing solutions |
| WO2016160089A1 (en) * | 2015-03-27 | 2016-10-06 | Novan, Inc. | Topical antiviral compositions, delivery systems, and methods of using the same |
| EP3177262A4 (en) * | 2014-08-08 | 2018-04-18 | Novan Inc. | Topical emulsions |
| US11166980B2 (en) * | 2016-04-13 | 2021-11-09 | Novan, Inc. | Compositions, systems, kits, and methods for treating an infection |
| GB2599818B (en) * | 2019-06-04 | 2024-01-31 | Thirty Respiratory Ltd | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract |
| CN112791096A (zh) * | 2020-12-31 | 2021-05-14 | 南京诺令生物科技有限公司 | 一种可自提供一氧化氮的洗鼻盐及其应用 |
-
2022
- 2022-12-16 US US18/719,012 patent/US20250049841A1/en active Pending
- 2022-12-16 AU AU2022409833A patent/AU2022409833A1/en active Pending
- 2022-12-16 CN CN202280092092.3A patent/CN118742298A/zh active Pending
- 2022-12-16 IL IL313526A patent/IL313526A/en unknown
- 2022-12-16 KR KR1020247024094A patent/KR20240125633A/ko active Pending
- 2022-12-16 EP EP22908737.4A patent/EP4447946A4/en active Pending
- 2022-12-16 WO PCT/US2022/081754 patent/WO2023114971A1/en not_active Ceased
- 2022-12-16 JP JP2024536373A patent/JP2024547022A/ja active Pending
- 2022-12-16 CA CA3240044A patent/CA3240044A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4262086B2 (ja) | エーロゾル化用に至適化されたトブラマイシン製剤 | |
| JP6774435B2 (ja) | 抗ウイルス活性を有する鼻づまり解除組成物 | |
| US12138343B2 (en) | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 | |
| RU2524304C2 (ru) | Применение соли ацетилсалициловой кислоты для лечения вирусных инфекций | |
| CN101389313A (zh) | 用于吸入疗法的雾化抗生素 | |
| US12171733B2 (en) | Bactericidal and virucidal pharmaceutical composition | |
| WO2016067283A1 (en) | Virucidal compositions comprising tannins for nasal and pulmonary administration | |
| RU2339403C2 (ru) | Композиции для профилактики и лечения симптомов, подобных симптомам простуды и гриппа, содержащие выбранные склеивающиеся со слизистой полимеры, и способы лечения | |
| WO2021236570A1 (en) | Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation | |
| JP5465182B2 (ja) | ポリアルキレンイミンを含むウイルス感染症治療薬 | |
| JP2024547022A5 (enExample) | ||
| JP2024128022A (ja) | 微生物感染を消毒、処置および予防するための組成物および方法 | |
| US20230158067A1 (en) | Silver nanoparticles for use in inhibiting and treating coronavirus infection | |
| EP3888629A1 (en) | Composition for treatment or prevention of a virus infection | |
| TWI762449B (zh) | 噴霧器用組成物 | |
| RU2843523C1 (ru) | Применение композиции на основе гепарина при лечении вирусных заболеваний легких, острых и/или хронических заболеваний легких с помощью ингалятора «мягкого тумана» или небулайзера с технологией вибрирующей сетки посредством ингаляционного пути введения | |
| JP5311825B2 (ja) | ２−イミダゾリン構造を有するα−交感神経興奮薬の新規な使用 | |
| JP2024547022A (ja) | 一酸化窒素放出性鼻腔用組成物及び、それを使用する方法 | |
| HK40086332A (zh) | 用於抑制和治疗冠状病毒感染的银纳米颗粒 | |
| EA023654B1 (ru) | Полимерный полисахарид из семян тамариндового дерева для применения в лечении сухого кашля | |
| EA048350B1 (ru) | Применение даларгина для профилактики орви и предотвращения развития осложнений при заболеваниях орви | |
| HK1253038B (zh) | 一种具有抗病毒活性的鼻塞疏通组合物 |